Search results for: 'drone market dimension analysis'

06 Jul 2017  |  Asia Pacific  |  Market Research

Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021

Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth

Infographics

×

There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer thera...

Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...

The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources remain persistent challenges for the diagnostics sector. Automation, a broad concept encompassing processes and practices that streamline workflows, save time, and manage increasing workloads, has become a key response to these issues. By combining ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across innovations in precision medicine, targeted drug delivery, RNA editing, biomanufacturing, cell and gene therapies. The research also comprises advances in single cell analysis, hybrid microbots, AI-powered diagnostic, bioprinting and non...